Thoracentesis and Paracentesis Market Size, Share and Trends 2026 to 2035

Revenue, 2025

USD 1.36 Bn

Forecast Year, 2035

USD 3.21 Bn

CAGR, 2026 - 2035

8.95%

Report Coverage

Global

What is Thoracentesis and Paracentesis Market Size in 2026?

The global thoracentesis and paracentesis market size was calculated at USD 1.36 billion in 2025 and is predicted to increase from USD 1.48 billion in 2026 to approximately USD 3.21 billion by 2035, expanding at a CAGR of 8.95% from 2026 to 2035. The market is experiencing robust growth due to the increasing incidence of chronic conditions such as liver cirrhosis, cancer, and heart failure, which cause the accumulation of fluid in the chest or abdominal cavity. There is an increasing demand for less invasive techniques, which ensure better outcomes.

Key Takeaways

• North America dominated the global thoracentesis and paracentesis market in 2025.
• Asia-Pacific is expected to grow rapidly at the highest CAGR from 2026 to 2035.
• By product type, the paracentesis kits segment dominated the market in 2025.
• By product type, the drainage catheters segment is expected to grow at the fastest CAGR in the market between 2026 and 2035.
• By indication, the ascites segment led the market in 2025.
• By indication, the pleural effusion segment is expected to grow with the highest CAGR in the market during the studied years.
• By end user, the hospitals segment registered its dominance over the market in 2025.
• By end user, the ambulatory surgical centers segment is expected to expand rapidly in the market in the coming years.

What is the Thoracentesis and Paracentesis Market?

The thoracentesis and paracentesis industry plays a vital role to play in the current clinical scenario, where the safe removal of excess fluid from the thoracic or abdominal cavities is essential. Thoracentesis and paracentesis procedures are performed to relieve symptoms or test the fluid around the lungs or abdomen. These procedures are commonly used in the diagnosis and treatment of patients with conditions such as pleural effusion, ascites, and cancer. The rise in the number of patients with chronic illness has led to a rise in the number of fluid drainage procedures performed worldwide.

How is AI Influencing the Thoracentesis and Paracentesis Market?

Artificial intelligence (AI) revolutionizes the market by improving the planning, monitoring, and decision-making for procedures. The introduction of AI in imaging systems enables the precise analysis of ultrasound or CT images, which helps in the precise placement of needles or the drainage of fluid. This, in turn, minimises the risk of adverse outcomes, such as injury to organs or infections.

AI also helps in the predictive analysis of the likelihood of the occurrence of pleural effusion or ascites, enabling healthcare professionals to take necessary measures and predict patient outcomes. Hospitals are incorporating AI into imaging systems and other digital healthcare systems to improve the efficiency of the procedures. Moreover, AI helps in the monitoring of the recovery of the patient, which helps improve the outcomes for the patient.

Primary Trends Influencing the Thoracentesis and Paracentesis Market

• Rising Adoption of Minimally Invasive Procedures: Thoracentesis and paracentesis are the two most popular minimally invasive techniques that are often adopted for the removal of fluid that accumulates in the chest or abdominal cavity. These two techniques are often adopted to reduce the risk of surgical complications, the length of stay in the hospital, and the recovery time of the patient.
• Increase in the Adoption of Ultrasound-Guided Techniques: The adoption of ultrasound-guided thoracentesis and paracentesis is witnessing an increase in modern healthcare facilities. This technique is often adopted to improve the success rate of procedures while avoiding the risk of complications such as damage to the internal organs and infection.
• Increasing Prevalence of Chronic Disease: The increasing incidence of chronic diseases such as liver cirrhosis, cancer, heart failure, and kidney disorders is causing an increase in the number of people suffering from pleural effusion and ascites. These conditions potentiate the need for thoracentesis and paracentesis procedures for the diagnosis and treatment of the diseases. As the incidence of chronic diseases increases, the demand for fluid drainage systems is also increasing.
• Growing Demand for Disposable Drainage Kits: Hospitals and other medical centers are increasingly using disposable thoracentesis and paracentesis kits to ensure a high standard of infection control. These disposal kits have made the preparation for the procedures easier, reducing the risk of cross-contamination. The ease of use of the disposal drainage kits is encouraging their use in hospitals, clinics, and other ambulatory surgical centers .
• Technological Advancements in Drainage Devices : Manufacturers of medical devices are always coming up with advanced thoracentesis and paracentesis devices, which are improving the efficiency of the procedures and the safety of the patient. For example, there are safety-engineered needles, catheters, and drainage systems, among other technological devices, which are assisting medical practitioners in the execution of the procedures and are largely contributing to market growth.

Market Scope

Segmental Insights

Product Type Insights

Why Did the Paracentesis Kits Segment Dominate the Thoracentesis and Paracentesis Market?

The paracentesis kits segment dominated the market in 2025, due to the high incidence rate of ascites resulting from liver cirrhosis, cancer, and other chronic liver diseases. Patients undergo multiple procedures, thereby increasing the need for paracentesis kits and boosting their availability. Paracentesis kits are available in sterile and single-use forms, reducing the risk of contamination among patients. Paracentesis procedure demonstrates high safety and efficacy, especially when performed under ultrasound guidance.

The drainage catheters segment is expected to show the fastest growth over the forecast period, due to their ability to drain fluid after surgical procedures. Drainage catheters ensure that the patient is comfortable and the procedure is efficient and free of complications. They are used in hospitals to treat conditions such as pleural effusion and ascites. Continuous innovation in the product line by manufacturers contributes to the segment's growth.

Indication Insights

How the Ascites Segment Led the Thoracentesis and Paracentesis Market?

The ascites segment led the market in 2025, due to the rising prevalence of liver cirrhosis and obesity. Ascites leads to certain complications, such as chronic abdominal discomfort, infection, hepatic hydrothorax, and kidney failure, necessitating a paracentesis procedure for fluid removal. Ascites is more common, affecting about 60,000 to 100,000 individuals globally across all ages and genders.

The pleural effusion segment is expected to gain the highest market share between 2026 and 2035 because of the increasing prevalence of lung cancer, pneumonia, tuberculosis, and heart failure, which cause fluid buildup in the pleural space. This, in turn, increased the need for thoracentesis, a procedure used to treat these conditions, in hospitals. The increasing geriatric population and the improvement in imaging guidance boost the segment's growth. Pleural effusion is expected to affect approximately 1.5 million people in the U.S. annually.

End User Insights

What Made Hospitals the Dominant Segment in the Thoracentesis and Paracentesis Market?

The hospitals segment held the largest revenue share of the market in 2025. This is because the number of diagnostic and therapeutic fluid drainage procedures is high in the hospital setting. In hospitals, the availability of imaging technologies such as ultrasound or CT is high, which increases the safety of the procedure. In addition, the availability of healthcare professionals in the hospitals increases the demand for the procedure among patients.

The ambulatory surgical centers segment is expected to witness the fastest growth in the market over the forecast period. The growing demand for outpatient care and advancements in healthcare technology augment the segment's growth. Ambulatory surgical centers have skilled professionals to perform advanced surgical procedures and provide personalized care. They save exorbitant costs and time for patients by providing outpatient services.

Regional Insights

Why North America Dominated the Thoracentesis and Paracentesis Market

North America held a major market share in 2025, due to its advanced healthcare infrastructure, high adoption of minimally invasive procedures, and strong presenceof leading medical device companies. The region also has a high investment in healthcare and an increasing prevalence of chronic diseases such as cancer, liver cirrhosis, and heart failure, potentiating the need for fluid drainage procedures. In addition, favorable remuneration policies and technological innovations by companies also contribute to market growth.

U.S. Market Trends

The U.S. leads the market in North America due to a robust healthcare infrastructure, the presence of key players, and the rising prevalence of chronic disorders.According to a recent analysis conducted from 2014 to 2022, radiologists performed 93,037 paracentesis and 50,537 thoracentesis procedures in the U.S. The rising adoption of advanced technologies and increasing healthcare expenditure propel the market.

How is Asia-Pacific Growing in the Thoracentesis and Paracentesis Market?

Asia-Pacific is expected to be the fastest-growing region in the coming years, due to rapid improvements in the healthcare infrastructure and increasing healthcare spending across countries such as China and India. The increasing incidence of liver-related ailments, cancer, and respiratory problems is boosting the demand for fistula drainage procedures. In addition, the increasing awareness about the procedure and the rise in the number of hospitals are also contributing to the growth of the market.

China Market Trends

China's market is driven by the growing healthcare infrastructure, rising population, and increasing investments in healthcare procedures. The Chinese government provides funding to hospitals and other healthcare organizations to adopt advanced medical devices. The increasing prevalence of cancer among the Chinese population leads to ascites or pleural effusion. According to a study, malignancy was the most common etiology of ascites among Chinese.

Will Europe Grow in the Thoracentesis and Paracentesis Market?

Europe is expected to grow at a notable CAGR in the foreseeable future. The growing demand for minimally invasive procedures, rapidly advancing healthcare infrastructure, and the rising prevalence of cancer and liver cirrhosis drive the market. Evolving regulatory landscapes and favorable government support foster market growth. Government bodies launch initiatives and provide funding for early diagnosis and treatment of chronic conditions. The availability of favorable reimbursement policies also enhances accessibility and affordability among patients.

Thoracentesis and Paracentesis Market Value Chain Analysis

• Research and Development

Advanced drainage kits, catheters, and imaging-guided systems are developed to ensure safety. Continuous innovation helps improve procedural accuracy, reduce complications, and enhance overall patient outcomes in fluid drainage procedures.

Key Players: BD (Becton Dickinson and Company), B. Braun Melsungen AG, Cook Medical.

• Manufacturing and Quality Control

Companies manufacture thoracentesis and paracentesis kits under stringent regulatory conditions to ensure the safety, efficacy, and quality of the products. Strict quality control and standardised production process help maintain reliability and compliance with international medical device regulations.

Key Players: Teleflex Incorporated, Cardinal Health

• Distribution and Healthcare Utilization

Medical distributors supply drainage kits to hospitals, clinics, and ambulatory care centers for diagnostic and therapeutic uses. Efficient distribution networks ensure timely product availability and support the growing demand for drainage procedures worldwide.

Key Players: Medline Industries, Smiths Medical

Thoracentesis and Paracentesis Market Companies

• Becton, Dickinson and Company (BD)
• Teleflex Incorporated
• Merit Medical Systems
• Argon Medical Devices
• Cook Medical
• Boston Scientific Corporation
• B. Braun Melsungen AG
• Cardinal Health
• Rocket Medical
• Medtronic

Segments Covered in the Report

By Product Type

• Paracentesis Kits
• Thoracentesis Kits
• Drainage Catheters
• Safety Needles

By Indication

• Ascites
• Pleural Effusion
• Other Indications

By End User

• Hospitals
• Ambulatory Surgery Centres
• Specialty Clinics

By Region

• North America
• Latin America
• Europe
• Asia-pacific
• Middle and East Africa